In highly invasive breast cancer, loss of PKD1 appears to promote invasion and metastasis, whereas PKD2 and upregulated PKD3 positively influence proliferation, chemoresistance and metastasis (Borges and Storz, 2013). Here, PKD1 is linked to breast carcinoma.